Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects

Purpose The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorptio...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of nutrition Vol. 57; no. 3; pp. 929 - 938
Main Authors Purpura, Martin, Lowery, Ryan P., Wilson, Jacob M., Mannan, Haider, Münch, Gerald, Razmovski-Naumovski, Valentina
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2018
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1436-6207
1436-6215
1436-6215
DOI10.1007/s00394-016-1376-9

Cover

Loading…
Abstract Purpose The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO). Methods Twelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period. Results CW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC 0−12 ) in comparison with the unformulated StdC. Conclusion The data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.
AbstractList The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO). Twelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period. CW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC ) in comparison with the unformulated StdC. The data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.
Purpose The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO). Methods Twelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period. Results CW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC 0−12 ) in comparison with the unformulated StdC. Conclusion The data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.
The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO).PURPOSEThe optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO).Twelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period.METHODSTwelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period.CW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC0-12) in comparison with the unformulated StdC.RESULTSCW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC0-12) in comparison with the unformulated StdC.The data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.CONCLUSIONThe data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.
PurposeThe optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO).MethodsTwelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period.ResultsCW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC0−12) in comparison with the unformulated StdC.ConclusionThe data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.
PURPOSE: The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO). METHODS: Twelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period. RESULTS: CW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC₀₋₁₂) in comparison with the unformulated StdC. CONCLUSION: The data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.
Author Razmovski-Naumovski, Valentina
Lowery, Ryan P.
Purpura, Martin
Münch, Gerald
Wilson, Jacob M.
Mannan, Haider
Author_xml – sequence: 1
  givenname: Martin
  surname: Purpura
  fullname: Purpura, Martin
  organization: Increnovo LLC
– sequence: 2
  givenname: Ryan P.
  surname: Lowery
  fullname: Lowery, Ryan P.
  organization: Department of Health Sciences and Human Performance, The University of Tampa
– sequence: 3
  givenname: Jacob M.
  surname: Wilson
  fullname: Wilson, Jacob M.
  organization: Department of Health Sciences and Human Performance, The University of Tampa
– sequence: 4
  givenname: Haider
  surname: Mannan
  fullname: Mannan, Haider
  organization: Centre for Health Research, School of Medicine, Western Sydney University
– sequence: 5
  givenname: Gerald
  orcidid: 0000-0002-4873-7779
  surname: Münch
  fullname: Münch, Gerald
  email: g.muench@westernsydney.edu.au
  organization: National Institute of Complementary Medicine, Western Sydney University, Molecular Medicine Research Group, School of Medicine, Western Sydney University
– sequence: 6
  givenname: Valentina
  surname: Razmovski-Naumovski
  fullname: Razmovski-Naumovski, Valentina
  organization: National Institute of Complementary Medicine, Western Sydney University, South Western Sydney Clinical School, School of Medicine, The University of New South Wales
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28204880$$D View this record in MEDLINE/PubMed
BookMark eNqFkkFv1DAQhS1URNuFH8AFReLCJTBjJ058QaoqaJEqcYGzZTtO61ViL3YSaf99vU1ZoBJw8kjzvec3mjknJz54S8hrhPcI0HxIAExUJSAvkTW8FM_IGVaMl5xifXKsoTkl5yltAYAyji_IKW0pVG0LZ2S58GrYJ5eK0Bed63sbrZ8K531Y1OQWW_QhjvOQ6-AfIDNHM4_OHxqFG3cxLLYroh1WPEQ1FNoFtSg3KO0GN-2zXXE3j8oXadZba6b0kjzv1ZDsq8d3Q75__vTt8rq8-Xr15fLipjQ1sKnErufCtNw2aOs8k6Yd09YIjaBrJkA1hlIt8lTQME0BtRUCKtZZpBxFxTbk4-q7m_VoO5Nny_nkLrpRxb0Mysk_O97dyduwyLrliJxlg3ePBjH8mG2a5OiSscOgvA1zkhRq1rZVS6v_othyAZwhpxl9-wTdhjnmTRwMsW6QVZnckDe_hz-m_rm9DOAKmBhSirY_IgjycCFyvRCZL0QeLkSKrGmeaIybHrab53fDP5V0Vab8i7-18Vfov4vuAWDW0NQ
CitedBy_id crossref_primary_10_1111_bcpt_13477
crossref_primary_10_1080_01635581_2020_1811883
crossref_primary_10_14336_AD_2022_1101
crossref_primary_10_3390_molecules27165236
crossref_primary_10_1016_j_ejphar_2020_173412
crossref_primary_10_3389_fnut_2022_905658
crossref_primary_10_1097_NT_0000000000000392
crossref_primary_10_1186_s12906_019_2699_x
crossref_primary_10_1016_j_cocis_2020_03_009
crossref_primary_10_3390_nu11071542
crossref_primary_10_3390_diagnostics11061118
crossref_primary_10_1007_s40263_019_00619_1
crossref_primary_10_1002_ptr_8023
crossref_primary_10_3390_cancers16142580
crossref_primary_10_3389_fbioe_2020_00050
crossref_primary_10_3390_ijms21186619
crossref_primary_10_3390_nu14010032
crossref_primary_10_1080_1028415X_2021_1913951
crossref_primary_10_1016_j_hermed_2019_100281
crossref_primary_10_3390_nu11102426
crossref_primary_10_3233_JAD_170188
crossref_primary_10_3390_molecules24071220
crossref_primary_10_1002_cbdv_202402083
crossref_primary_10_1007_s11357_024_01092_5
crossref_primary_10_1080_17425247_2020_1813108
crossref_primary_10_31146_1682_8658_ecg_229_9_147_160
crossref_primary_10_1002_jat_4434
crossref_primary_10_3390_molecules25122791
crossref_primary_10_3390_pharmaceutics13122137
crossref_primary_10_21518_2079_701X_2021_15_158_163
crossref_primary_10_3390_molecules24162930
crossref_primary_10_1016_j_fbio_2023_103043
crossref_primary_10_2174_0929867331666230809100335
crossref_primary_10_3390_ijms25073617
crossref_primary_10_1016_j_intimp_2023_110231
crossref_primary_10_1038_s41598_021_85437_6
crossref_primary_10_1021_acs_jafc_1c07198
crossref_primary_10_3390_ph16071038
crossref_primary_10_1016_j_heliyon_2023_e12829
crossref_primary_10_1016_j_carbpol_2019_03_083
crossref_primary_10_1089_jmf_2023_0185
crossref_primary_10_3390_life11101007
crossref_primary_10_1007_s11064_021_03499_4
crossref_primary_10_1002_jat_3903
crossref_primary_10_1016_j_phrs_2019_104335
crossref_primary_10_3389_fnut_2022_865497
crossref_primary_10_1007_s11095_023_03500_5
crossref_primary_10_1021_acsomega_2c07326
crossref_primary_10_3389_fnut_2018_00025
crossref_primary_10_3390_antibiotics11020135
crossref_primary_10_1016_j_biopha_2023_114758
crossref_primary_10_3390_ijms22136829
crossref_primary_10_1002_ptr_7158
crossref_primary_10_1002_ptr_5931
crossref_primary_10_3390_foods12214000
crossref_primary_10_1007_s00394_018_1766_2
crossref_primary_10_1080_21691401_2018_1442345
crossref_primary_10_1021_acsptsci_2c00012
crossref_primary_10_3390_ijms26020855
crossref_primary_10_1039_C9MD00099B
crossref_primary_10_1111_dth_12511
crossref_primary_10_1039_D3DT01351K
crossref_primary_10_1002_bab_1891
crossref_primary_10_3390_pharmaceutics13101715
crossref_primary_10_1615_CritRevOncog_2023045587
crossref_primary_10_1016_j_joim_2018_07_001
crossref_primary_10_1093_jpp_rgab028
crossref_primary_10_1016_j_foodchem_2021_130612
crossref_primary_10_3390_nu14245347
crossref_primary_10_3390_antiox10111826
crossref_primary_10_3390_plants11192517
crossref_primary_10_1038_s41598_020_70921_2
crossref_primary_10_1007_s12325_022_02081_w
crossref_primary_10_1080_10408398_2024_2336051
crossref_primary_10_1007_s10847_018_0856_3
crossref_primary_10_2174_0113816128279330231129180250
crossref_primary_10_1016_j_biopha_2023_114224
crossref_primary_10_3390_ijms25084162
crossref_primary_10_1007_s11356_022_20137_w
crossref_primary_10_18632_aging_101787
crossref_primary_10_1016_j_biochi_2020_01_004
crossref_primary_10_1080_07315724_2017_1358118
crossref_primary_10_1002_ptr_8220
crossref_primary_10_1016_j_jfoodeng_2024_112441
crossref_primary_10_2903_j_efsa_2020_6146
crossref_primary_10_3390_biom11030401
crossref_primary_10_3390_molecules25061397
crossref_primary_10_1097_CAD_0000000000001639
crossref_primary_10_1007_s12013_020_00922_5
crossref_primary_10_1186_s12906_021_03207_3
crossref_primary_10_1016_j_jddst_2024_106543
crossref_primary_10_1016_j_jddst_2019_03_020
crossref_primary_10_1007_s10753_019_01010_4
crossref_primary_10_1016_j_lfs_2021_120279
crossref_primary_10_3390_pharmaceutics15092345
crossref_primary_10_1007_s13318_019_00545_z
crossref_primary_10_3390_antiox13030331
crossref_primary_10_1002_mnfr_202100613
crossref_primary_10_1016_j_indcrop_2021_114050
crossref_primary_10_1002_biof_1828
crossref_primary_10_1002_mnfr_202200798
crossref_primary_10_1016_j_ctim_2021_102775
crossref_primary_10_1016_j_fbio_2021_101335
crossref_primary_10_3390_pharmaceutics17030288
crossref_primary_10_1016_j_prmcm_2021_100025
crossref_primary_10_3390_pharmaceutics15020382
crossref_primary_10_22207_JPAM_13_2_55
crossref_primary_10_1016_j_phymed_2022_154306
crossref_primary_10_1016_j_carpta_2025_100775
crossref_primary_10_14309_crj_0000000000000941
crossref_primary_10_1002_ptr_7190
crossref_primary_10_1016_j_biopha_2024_117314
crossref_primary_10_1039_D1FO02696H
crossref_primary_10_3390_ijms22094666
crossref_primary_10_1089_jmf_2020_0074
crossref_primary_10_1111_1756_185X_13688
crossref_primary_10_1111_myc_13051
crossref_primary_10_1002_ptr_6943
crossref_primary_10_1007_s13596_023_00712_3
crossref_primary_10_1016_j_jff_2021_104410
crossref_primary_10_1016_j_jconrel_2022_05_048
crossref_primary_10_1016_j_jddst_2019_101205
crossref_primary_10_3390_ijms20051084
crossref_primary_10_3390_polym13040577
crossref_primary_10_1080_09553002_2020_1739773
crossref_primary_10_1021_acs_jafc_3c04990
crossref_primary_10_3390_molecules23102485
crossref_primary_10_1111_1541_4337_12626
crossref_primary_10_2174_1573413719666230110124509
crossref_primary_10_3390_nu13051519
crossref_primary_10_1080_17425255_2019_1650914
crossref_primary_10_1016_j_freeradbiomed_2021_05_003
crossref_primary_10_2139_ssrn_4141969
crossref_primary_10_3390_app13137809
crossref_primary_10_3390_life14091138
crossref_primary_10_21518_ms2023_394
crossref_primary_10_53879_id_61_11_14377
crossref_primary_10_1016_j_ijpharm_2022_122474
crossref_primary_10_1007_s00702_022_02480_x
crossref_primary_10_3390_ph17040489
crossref_primary_10_1093_bbb_zbac161
crossref_primary_10_2144_fsoa_2020_0131
crossref_primary_10_1016_j_ijbiomac_2022_11_248
crossref_primary_10_3390_ph15050503
Cites_doi 10.4049/jimmunol.171.7.3863
10.3389/fnmol.2015.00024
10.1007/s10875-006-9066-7
10.4103/1673-5374.162686
10.1016/j.fct.2011.05.001
10.1271/bbb.100137
10.1248/bpb.34.660
10.1208/s12248-015-9811-z
10.1016/j.nutres.2006.08.004
10.3109/00498257809069589
10.3109/09637486.2015.1095865
10.1073/pnas.1016217108
10.1186/1475-2891-13-11
10.1016/j.jpba.2005.09.032
10.1016/j.carbpol.2013.08.078
10.1007/s00018-008-7452-4
10.1021/mp700113r
10.1055/s-2006-960004
10.1186/1472-6882-6-10
10.3233/JAD-2010-1233
10.1016/0006-3002(61)90535-2
10.1158/1055-9965.EPI-07-2693
10.1002/ptr.4639
10.1021/np1007262
10.1111/j.1600-0773.1978.tb02240.x
10.1186/1475-2891-11-79
10.1007/978-0-387-46401-5_3
10.1155/2014/309129
10.1016/j.cmpb.2010.01.007
10.1002/mnfr.201300724
10.1074/jbc.M608189200
10.1002/med.2610140304
10.4103/0250-474X.44591
10.1006/phrs.1998.0404
10.1016/j.neuint.2015.10.011
ContentType Journal Article
Copyright The Author(s) 2017
European Journal of Nutrition is a copyright of Springer, (2017). All Rights Reserved.
Copyright_xml – notice: The Author(s) 2017
– notice: European Journal of Nutrition is a copyright of Springer, (2017). All Rights Reserved.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7RQ
7RV
7TS
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
DOI 10.1007/s00394-016-1376-9
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Career & Technical Education Database
Nursing & Allied Health Database
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
Health & Medical Collection (Alumni)
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
Physical Education Index
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Career and Technical Education
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
ProQuest One Academic Middle East (New)
AGRICOLA
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Diet & Clinical Nutrition
EISSN 1436-6215
EndPage 938
ExternalDocumentID PMC5861163
28204880
10_1007_s00394_016_1376_9
Genre Randomized Controlled Trial
Journal Article
Comparative Study
GrantInformation_xml – fundername: Wacker AG
– fundername: ;
GroupedDBID ---
-58
-5G
-BR
-EM
-Y2
-~C
.86
.VR
04C
06C
06D
0R~
0VY
1N0
2.D
203
29G
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2QV
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5VS
67Z
6NX
6PF
7RQ
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAIKT
AAJBT
AAJKR
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACUHS
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADOJX
ADPHR
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYJHY
AZFZN
AZQEC
B-.
B0M
BA0
BDATZ
BENPR
BGNMA
BKEYQ
BKNYI
BMSDO
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
DXH
EAD
EAP
EAS
EBB
EBC
EBD
EBLON
EBS
EBX
ECF
ECGQY
ECT
EHN
EIHBH
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPT
ESBYG
ESTFP
ESX
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
LAS
LLZTM
M0R
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9N
PCD
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOR
QOS
Q~Q
R89
R9I
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3B
SAP
SCLPG
SCM
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
Y6R
YLTOR
Z45
Z5O
Z7U
Z7V
Z7W
Z81
Z82
Z83
Z85
Z86
Z87
Z8O
Z8P
Z8Q
Z8U
Z8V
Z8W
Z8Z
Z91
ZMTXR
~8M
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7QP
7TS
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c503t-1df69c86e71e5215b2d3bec9b10b5390a7c22b9236073b201be99043de1261943
IEDL.DBID U2A
ISSN 1436-6207
1436-6215
IngestDate Thu Aug 21 13:57:51 EDT 2025
Mon Jul 21 10:50:16 EDT 2025
Tue Aug 05 10:44:24 EDT 2025
Sat Aug 16 15:21:36 EDT 2025
Mon Jul 21 05:51:10 EDT 2025
Tue Jul 01 02:53:32 EDT 2025
Thu Apr 24 23:02:06 EDT 2025
Fri Feb 21 02:35:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Cyclodextrin
Curcumin
Bioavailability
Plasma pharmacokinetics
Humans
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c503t-1df69c86e71e5215b2d3bec9b10b5390a7c22b9236073b201be99043de1261943
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-4873-7779
OpenAccessLink https://link.springer.com/10.1007/s00394-016-1376-9
PMID 28204880
PQID 2015713406
PQPubID 34175
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5861163
proquest_miscellaneous_2053884824
proquest_miscellaneous_1869063162
proquest_journals_2015713406
pubmed_primary_28204880
crossref_primary_10_1007_s00394_016_1376_9
crossref_citationtrail_10_1007_s00394_016_1376_9
springer_journals_10_1007_s00394_016_1376_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle European journal of nutrition
PublicationTitleAbbrev Eur J Nutr
PublicationTitleAlternate Eur J Nutr
PublicationYear 2018
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Bharti, Donato, Aggarwal (CR4) 2003; 171
Antony, Merina, Iyer, Judy, Lennertz, Joyal (CR34) 2008; 70
Yallapu, Nagesh, Jaggi, Chauhan (CR36) 2015; 17
Lao, Ruffin, Normolle, Heath, Murray, Bailey, Boggs, Crowell, Rock, Brenner (CR37) 2006; 6
Cuomo, Appendino, Dern, Schneider, McKinnon, Brown, Togni, Dixon (CR29) 2011; 74
Abe, Hashimoto, Horie (CR10) 1999; 39
Ammon, Wahl (CR19) 1991; 57
Liu, Lou, Zhao, Fan (CR32) 2006; 40
Vareed, Kakarala, Ruffin, Crowell, Normolle, Djuric, Brenner (CR23) 2008; 17
Tan, Calani, Bresciani, Dall’asta, Faccini, Augustin, Gras, Del Rio (CR24) 2015; 66
Terao, Nakata, Fukumi, Schmid, Arima, Hirayama, Uekama (CR28) 2006; 26
Szejtli (CR25) 1994; 14
Zhang, Huo, Zhou, Xie (CR33) 2010; 99
Millington, Sonego, Karunaweera, Rangel, Aldrich-Wright, Campbell, Gyengesi, Münch (CR6) 2014; 2014
Bhattacharyya, Mandal, Saha, Sen, Das, Sa (CR12) 2007; 282
Ireson, Orr, Jones, Verschoyle, Lim, Luo, Howells, Plummer, Jukes, Williams, Steward, Gescher (CR21) 2001; 61
Wakabayashi, Fishman (CR30) 1961; 48
Jager, Lowery, Calvanese, Joy, Purpura, Wilson (CR31) 2014; 13
Asher, Spelman (CR11) 2013; 19
Dadhaniya, Patel, Muchhara, Bhadja, Mathuria, Vachhani, Soni (CR38) 2011; 49
Venigalla, Gyengesi, Münch (CR2) 2015; 10
Hassaninasab, Hashimoto, Tomita-Yokotani, Kobayashi (CR22) 2011; 108
Pinho, Grootveld, Soares, Henriques (CR26) 2014; 101
Wahlstrom, Blennow (CR17) 1978; 43
Schiborr, Kocher, Behnam, Jandasek, Toelstede, Frank (CR18) 2014; 58
Sasaki, Sunagawa, Takahashi, Imaizumi, Fukuda, Hashimoto, Wada, Katanasaka, Kakeya, Fujita, Hasegawa, Morimoto (CR35) 2011; 34
Hatcher, Planalp, Cho, Torti, Torti (CR1) 2008; 65
Karunaweera, Raju, Gyengesi, Münch (CR5) 2015; 8
Holder, Plummer, Ryan (CR20) 1978; 8
Venigalla, Sonego, Gyengesi, Sharman, Münch (CR3) 2015
Chandran, Goel (CR13) 2012; 26
Jagetia, Aggarwal (CR14) 2007; 27
Lev-Ari, Maimon, Strier, Kazanov, Arber (CR9) 2006; 4
DiSilvestro, Joseph, Zhao, Bomser (CR15) 2012; 11
Menon, Sudheer (CR8) 2007; 595
Ikeda, Uchida, Ichikawa, Watanabe, Uekaji, Nakata, Terao, Yano (CR27) 2010; 74
Hansen, Krautwald, Maczurek, Stuchbury, Fromm, Steele, Schulz, Garcia, Castillo, Korner, Münch (CR7) 2010; 19
Anand, Kunnumakkara, Newman, Aggarwal (CR16) 2007; 4
M Venigalla (1376_CR2) 2015; 10
P Dadhaniya (1376_CR38) 2011; 49
S Lev-Ari (1376_CR9) 2006; 4
CD Lao (1376_CR37) 2006; 6
B Antony (1376_CR34) 2008; 70
R Jager (1376_CR31) 2014; 13
SK Vareed (1376_CR23) 2008; 17
E Pinho (1376_CR26) 2014; 101
A Liu (1376_CR32) 2006; 40
GC Jagetia (1376_CR14) 2007; 27
C Ireson (1376_CR21) 2001; 61
AC Bharti (1376_CR4) 2003; 171
E Hansen (1376_CR7) 2010; 19
H Hatcher (1376_CR1) 2008; 65
VP Menon (1376_CR8) 2007; 595
GM Holder (1376_CR20) 1978; 8
K Terao (1376_CR28) 2006; 26
J Szejtli (1376_CR25) 1994; 14
RA DiSilvestro (1376_CR15) 2012; 11
Y Zhang (1376_CR33) 2010; 99
HP Ammon (1376_CR19) 1991; 57
N Karunaweera (1376_CR5) 2015; 8
Y Abe (1376_CR10) 1999; 39
S Ikeda (1376_CR27) 2010; 74
S Bhattacharyya (1376_CR12) 2007; 282
J Cuomo (1376_CR29) 2011; 74
P Anand (1376_CR16) 2007; 4
B Wahlstrom (1376_CR17) 1978; 43
C Schiborr (1376_CR18) 2014; 58
A Hassaninasab (1376_CR22) 2011; 108
H Sasaki (1376_CR35) 2011; 34
M Venigalla (1376_CR3) 2015
GN Asher (1376_CR11) 2013; 19
C Millington (1376_CR6) 2014; 2014
B Chandran (1376_CR13) 2012; 26
S Tan (1376_CR24) 2015; 66
MM Yallapu (1376_CR36) 2015; 17
M Wakabayashi (1376_CR30) 1961; 48
References_xml – volume: 171
  start-page: 3863
  issue: 7
  year: 2003
  end-page: 3871
  ident: CR4
  article-title: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.7.3863
– volume: 8
  start-page: 24
  year: 2015
  ident: CR5
  article-title: Plant polyphenols as inhibitors of NF-kappaB induced cytokine production-a potential anti-inflammatory treatment for Alzheimer’s disease?
  publication-title: Front Mol Neurosci
  doi: 10.3389/fnmol.2015.00024
– volume: 61
  start-page: 1058
  issue: 3
  year: 2001
  end-page: 1064
  ident: CR21
  article-title: Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production
  publication-title: Cancer Res
– volume: 19
  start-page: 20
  issue: 2
  year: 2013
  end-page: 22
  ident: CR11
  article-title: Clinical utility of curcumin extract
  publication-title: Altern Ther Health Med
– volume: 27
  start-page: 19
  issue: 1
  year: 2007
  end-page: 35
  ident: CR14
  article-title: “Spicing up” of the immune system by curcumin
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-006-9066-7
– volume: 10
  start-page: 1181
  issue: 8
  year: 2015
  end-page: 1185
  ident: CR2
  article-title: Curcumin and Apigenin—novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.162686
– volume: 49
  start-page: 1834
  issue: 8
  year: 2011
  end-page: 1842
  ident: CR38
  article-title: Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies
  publication-title: Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc
  doi: 10.1016/j.fct.2011.05.001
– volume: 74
  start-page: 1452
  issue: 7
  year: 2010
  end-page: 1457
  ident: CR27
  article-title: Complexation of tocotrienol with gamma-cyclodextrin enhances intestinal absorption of tocotrienol in rats
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.100137
– volume: 34
  start-page: 660
  issue: 5
  year: 2011
  end-page: 665
  ident: CR35
  article-title: Innovative preparation of curcumin for improved oral bioavailability
  publication-title: Biol Pharm Bull
  doi: 10.1248/bpb.34.660
– volume: 17
  start-page: 1341
  issue: 6
  year: 2015
  end-page: 1356
  ident: CR36
  article-title: Therapeutic applications of curcumin nanoformulations
  publication-title: AAPS J
  doi: 10.1208/s12248-015-9811-z
– volume: 26
  start-page: 503
  year: 2006
  end-page: 508
  ident: CR28
  article-title: Enhancement of oral bioavailability of coenzyme Q10 by complexation with gamma-cyclodextrin in healthy adults
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2006.08.004
– volume: 8
  start-page: 761
  issue: 12
  year: 1978
  end-page: 768
  ident: CR20
  article-title: The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat
  publication-title: Xenobiotica
  doi: 10.3109/00498257809069589
– volume: 66
  start-page: 790
  issue: 7
  year: 2015
  end-page: 796
  ident: CR24
  article-title: The degradation of curcuminoids in a human faecal fermentation model
  publication-title: Int J Food Sci Nutr
  doi: 10.3109/09637486.2015.1095865
– volume: 108
  start-page: 6615
  issue: 16
  year: 2011
  end-page: 6620
  ident: CR22
  article-title: Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1016217108
– volume: 13
  start-page: 11
  year: 2014
  ident: CR31
  article-title: Comparative absorption of curcumin formulations
  publication-title: Nutr J
  doi: 10.1186/1475-2891-13-11
– volume: 40
  start-page: 720
  issue: 3
  year: 2006
  end-page: 727
  ident: CR32
  article-title: Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2005.09.032
– volume: 101
  start-page: 121
  year: 2014
  end-page: 135
  ident: CR26
  article-title: Cyclodextrins as encapsulation agents for plant bioactive compounds
  publication-title: Carbohydr Polym
  doi: 10.1016/j.carbpol.2013.08.078
– volume: 65
  start-page: 1631
  issue: 11
  year: 2008
  end-page: 1652
  ident: CR1
  article-title: Curcumin: from ancient medicine to current clinical trials
  publication-title: Cell Mol Life Sci CMLS
  doi: 10.1007/s00018-008-7452-4
– volume: 4
  start-page: 807
  issue: 6
  year: 2007
  end-page: 818
  ident: CR16
  article-title: Bioavailability of curcumin: problems and promises
  publication-title: Mol Pharm
  doi: 10.1021/mp700113r
– volume: 57
  start-page: 1
  issue: 1
  year: 1991
  end-page: 7
  ident: CR19
  article-title: Pharmacology of Curcuma longa
  publication-title: Planta Med
  doi: 10.1055/s-2006-960004
– volume: 6
  start-page: 10
  year: 2006
  ident: CR37
  article-title: Dose escalation of a curcuminoid formulation
  publication-title: BMC Complement Altern Med
  doi: 10.1186/1472-6882-6-10
– volume: 19
  start-page: 451
  issue: 2
  year: 2010
  end-page: 464
  ident: CR7
  article-title: A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and neuroprotective compounds
  publication-title: J Alzheimer’s Dis
  doi: 10.3233/JAD-2010-1233
– volume: 48
  start-page: 195
  year: 1961
  end-page: 197
  ident: CR30
  article-title: A method for freeing Helix pomatia beta-glucuronidase of sulfatase by simple heat denaturation
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0006-3002(61)90535-2
– year: 2015
  ident: CR3
  article-title: Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease
  publication-title: Neurochem Int
– volume: 4
  start-page: 21
  issue: 1
  year: 2006
  end-page: 26
  ident: CR9
  article-title: Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines
  publication-title: J Soc Integr Oncol
– volume: 17
  start-page: 1411
  issue: 6
  year: 2008
  end-page: 1417
  ident: CR23
  article-title: Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-07-2693
– volume: 26
  start-page: 1719
  issue: 11
  year: 2012
  end-page: 1725
  ident: CR13
  article-title: A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis
  publication-title: Phytother Res PTR
  doi: 10.1002/ptr.4639
– volume: 74
  start-page: 664
  issue: 4
  year: 2011
  end-page: 669
  ident: CR29
  article-title: Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation
  publication-title: J Nat Prod
  doi: 10.1021/np1007262
– volume: 43
  start-page: 86
  issue: 2
  year: 1978
  end-page: 92
  ident: CR17
  article-title: A study on the fate of curcumin in the rat
  publication-title: Acta Pharmacol Toxicol (Copenh)
  doi: 10.1111/j.1600-0773.1978.tb02240.x
– volume: 11
  start-page: 79
  year: 2012
  ident: CR15
  article-title: Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people
  publication-title: Nutr J
  doi: 10.1186/1475-2891-11-79
– volume: 595
  start-page: 105
  year: 2007
  end-page: 125
  ident: CR8
  article-title: Antioxidant and anti-inflammatory properties of curcumin
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-0-387-46401-5_3
– volume: 2014
  start-page: 309129
  year: 2014
  ident: CR6
  article-title: Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
  publication-title: Biomed Res Int
  doi: 10.1155/2014/309129
– volume: 99
  start-page: 306
  issue: 3
  year: 2010
  end-page: 314
  ident: CR33
  article-title: PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
  publication-title: Comput Methods Programs Biomed
  doi: 10.1016/j.cmpb.2010.01.007
– volume: 39
  start-page: 41
  issue: 1
  year: 1999
  end-page: 47
  ident: CR10
  article-title: Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages
  publication-title: Pharmacol Res Off J Italian Pharmacol Soc
– volume: 58
  start-page: 516
  issue: 3
  year: 2014
  end-page: 527
  ident: CR18
  article-title: The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201300724
– volume: 282
  start-page: 15954
  issue: 22
  year: 2007
  end-page: 15964
  ident: CR12
  article-title: Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M608189200
– volume: 14
  start-page: 353
  issue: 3
  year: 1994
  end-page: 386
  ident: CR25
  article-title: Medicinal applications of cyclodextrins
  publication-title: Med Res Rev
  doi: 10.1002/med.2610140304
– volume: 70
  start-page: 445
  issue: 4
  year: 2008
  end-page: 449
  ident: CR34
  article-title: A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin
  publication-title: Indian J Pharm Sci
  doi: 10.4103/0250-474X.44591
– volume: 14
  start-page: 353
  issue: 3
  year: 1994
  ident: 1376_CR25
  publication-title: Med Res Rev
  doi: 10.1002/med.2610140304
– volume: 171
  start-page: 3863
  issue: 7
  year: 2003
  ident: 1376_CR4
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.7.3863
– volume: 66
  start-page: 790
  issue: 7
  year: 2015
  ident: 1376_CR24
  publication-title: Int J Food Sci Nutr
  doi: 10.3109/09637486.2015.1095865
– volume: 70
  start-page: 445
  issue: 4
  year: 2008
  ident: 1376_CR34
  publication-title: Indian J Pharm Sci
  doi: 10.4103/0250-474X.44591
– volume: 74
  start-page: 1452
  issue: 7
  year: 2010
  ident: 1376_CR27
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.100137
– volume: 40
  start-page: 720
  issue: 3
  year: 2006
  ident: 1376_CR32
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2005.09.032
– volume: 65
  start-page: 1631
  issue: 11
  year: 2008
  ident: 1376_CR1
  publication-title: Cell Mol Life Sci CMLS
  doi: 10.1007/s00018-008-7452-4
– volume: 11
  start-page: 79
  year: 2012
  ident: 1376_CR15
  publication-title: Nutr J
  doi: 10.1186/1475-2891-11-79
– volume: 4
  start-page: 21
  issue: 1
  year: 2006
  ident: 1376_CR9
  publication-title: J Soc Integr Oncol
– volume: 6
  start-page: 10
  year: 2006
  ident: 1376_CR37
  publication-title: BMC Complement Altern Med
  doi: 10.1186/1472-6882-6-10
– volume: 39
  start-page: 41
  issue: 1
  year: 1999
  ident: 1376_CR10
  publication-title: Pharmacol Res Off J Italian Pharmacol Soc
  doi: 10.1006/phrs.1998.0404
– volume: 43
  start-page: 86
  issue: 2
  year: 1978
  ident: 1376_CR17
  publication-title: Acta Pharmacol Toxicol (Copenh)
  doi: 10.1111/j.1600-0773.1978.tb02240.x
– volume: 13
  start-page: 11
  year: 2014
  ident: 1376_CR31
  publication-title: Nutr J
  doi: 10.1186/1475-2891-13-11
– volume: 10
  start-page: 1181
  issue: 8
  year: 2015
  ident: 1376_CR2
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.162686
– volume: 61
  start-page: 1058
  issue: 3
  year: 2001
  ident: 1376_CR21
  publication-title: Cancer Res
– volume: 74
  start-page: 664
  issue: 4
  year: 2011
  ident: 1376_CR29
  publication-title: J Nat Prod
  doi: 10.1021/np1007262
– volume: 99
  start-page: 306
  issue: 3
  year: 2010
  ident: 1376_CR33
  publication-title: Comput Methods Programs Biomed
  doi: 10.1016/j.cmpb.2010.01.007
– volume: 26
  start-page: 1719
  issue: 11
  year: 2012
  ident: 1376_CR13
  publication-title: Phytother Res PTR
  doi: 10.1002/ptr.4639
– volume: 57
  start-page: 1
  issue: 1
  year: 1991
  ident: 1376_CR19
  publication-title: Planta Med
  doi: 10.1055/s-2006-960004
– volume: 58
  start-page: 516
  issue: 3
  year: 2014
  ident: 1376_CR18
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201300724
– volume: 19
  start-page: 20
  issue: 2
  year: 2013
  ident: 1376_CR11
  publication-title: Altern Ther Health Med
– volume: 26
  start-page: 503
  year: 2006
  ident: 1376_CR28
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2006.08.004
– volume: 27
  start-page: 19
  issue: 1
  year: 2007
  ident: 1376_CR14
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-006-9066-7
– volume: 595
  start-page: 105
  year: 2007
  ident: 1376_CR8
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-0-387-46401-5_3
– volume: 4
  start-page: 807
  issue: 6
  year: 2007
  ident: 1376_CR16
  publication-title: Mol Pharm
  doi: 10.1021/mp700113r
– volume: 101
  start-page: 121
  year: 2014
  ident: 1376_CR26
  publication-title: Carbohydr Polym
  doi: 10.1016/j.carbpol.2013.08.078
– volume: 17
  start-page: 1411
  issue: 6
  year: 2008
  ident: 1376_CR23
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-07-2693
– volume: 17
  start-page: 1341
  issue: 6
  year: 2015
  ident: 1376_CR36
  publication-title: AAPS J
  doi: 10.1208/s12248-015-9811-z
– volume: 48
  start-page: 195
  year: 1961
  ident: 1376_CR30
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0006-3002(61)90535-2
– year: 2015
  ident: 1376_CR3
  publication-title: Neurochem Int
  doi: 10.1016/j.neuint.2015.10.011
– volume: 108
  start-page: 6615
  issue: 16
  year: 2011
  ident: 1376_CR22
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1016217108
– volume: 282
  start-page: 15954
  issue: 22
  year: 2007
  ident: 1376_CR12
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M608189200
– volume: 8
  start-page: 761
  issue: 12
  year: 1978
  ident: 1376_CR20
  publication-title: Xenobiotica
  doi: 10.3109/00498257809069589
– volume: 19
  start-page: 451
  issue: 2
  year: 2010
  ident: 1376_CR7
  publication-title: J Alzheimer’s Dis
  doi: 10.3233/JAD-2010-1233
– volume: 34
  start-page: 660
  issue: 5
  year: 2011
  ident: 1376_CR35
  publication-title: Biol Pharm Bull
  doi: 10.1248/bpb.34.660
– volume: 49
  start-page: 1834
  issue: 8
  year: 2011
  ident: 1376_CR38
  publication-title: Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc
  doi: 10.1016/j.fct.2011.05.001
– volume: 8
  start-page: 24
  year: 2015
  ident: 1376_CR5
  publication-title: Front Mol Neurosci
  doi: 10.3389/fnmol.2015.00024
– volume: 2014
  start-page: 309129
  year: 2014
  ident: 1376_CR6
  publication-title: Biomed Res Int
  doi: 10.1155/2014/309129
SSID ssj0002361
Score 2.565158
Snippet Purpose The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can...
The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form...
PurposeThe optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can...
PURPOSE: The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD)...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 929
SubjectTerms absorption
Adult
Antineoplastic Agents, Phytogenic - administration & dosage
Antineoplastic Agents, Phytogenic - blood
Antineoplastic Agents, Phytogenic - chemistry
Antineoplastic Agents, Phytogenic - metabolism
Antioxidants - administration & dosage
Antioxidants - analysis
Antioxidants - chemistry
Antioxidants - metabolism
Area Under Curve
Bioavailability
Chemistry
Chemistry and Materials Science
Cohort Studies
Cross-Over Studies
Curcumin
Curcumin - administration & dosage
Curcumin - analogs & derivatives
Curcumin - analysis
Curcumin - chemistry
Curcumin - metabolism
Cyclodextrin
Diarylheptanoids
Dietary Supplements
dispersibility
Double-Blind Method
Essential oils
Female
Food Additives - chemistry
Food Handling
gamma-cyclodextrin
gamma-Cyclodextrins - chemistry
Human subjects
Humans
Intestinal Absorption
Intestine
Lipophilic
Male
Nutrition
Nutritive Value
Oral administration
Original Contribution
Pharmacokinetics
rhizomes
Solubility
turmeric
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Pa90wDBZbd9llbO1-ZO2KC2OHjUBsJ05yGmVbKYX2tMK7hTh2WOA1aZvkQf_7So6T8lbaY2Il2MiWJVn-PoCv2DnFVWlCo7kIY2PLUGclxjxS1bzOo6h0d2HOL9TpZXy2SlY-4db7ssrZJjpDbbqKcuQYpPOE7j1G6uf1TUisUXS66ik0XsIrgi6j4CtdLQEXgaO7gCuWKlQiSudTzciBiEoCxeWEwpeqMN_elx45m49rJv87OHX70clbeOMdSXY8af4dvLDtLuwdtxhEX92xb8yVdrqc-S4Evxs74DsPArpmFzMG_x5sZlgS1tVspksZWOPZUjeWkVvrSb6cUDXeVuNV01IDa1xSwho2XYpBcbryz3TTlZuyWU8o4Hf4O-bYAFk_asr89O_h8uTP31-noSdjCKskkkPITa3yKlM25Ra3_EQLI1H_ueaRTmSOOq2E0OguKjQaGrWlLW50sTSWU5AWyw-w03at_QQsqqVJ0KzyStg4s0lWYxAmUl6m2uRlrQKIZlUUlUcqJ8KMdbFgLDvtFVSdRtor8gC-L59cTzAdzwkfzPot_Irti4f5FcDR0oxrjQ5QytZ2Y184-i4luRJPywi0alkWZyIO4OM0ZZYeYXjrDGYA6dZkWgQI63u7pW3-OczvJFMcXecAfszT7qHrTw708_MD3YfX-JBNdUgHsDPcjvYLuliDPnTr6B5q9STl
  priority: 102
  providerName: ProQuest
Title Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
URI https://link.springer.com/article/10.1007/s00394-016-1376-9
https://www.ncbi.nlm.nih.gov/pubmed/28204880
https://www.proquest.com/docview/2015713406
https://www.proquest.com/docview/1869063162
https://www.proquest.com/docview/2053884824
https://pubmed.ncbi.nlm.nih.gov/PMC5861163
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dj5QwEJ94dw_6YnTPD85zUxPjg4aEFijlcZfb9aJxY4ybrE-EQokke6w5YJP7729aKGY9z8QXeJgBCjNMZ9qZ3wC8xcFxyrPCLSRlblCozJUiw5jH5yUtY8_LTC3MlxW_XAefNuFmqONubLa73ZI0lnosdtNlpDpjQuPmRdyNj-AkxNBdq_WazUbzq9FETEmRz13OvMhuZf7tFoeT0R0P826i5B-7pWYSWj6Bx4P3SGa9uJ_CA1VP4HRWY-R8dUPeEZPPaRbKJ_Awsb3cJuBcVKpF-oACuiUrC8J_CnuLS0J2JbH9UlpSDe1S94pov3bo8mWY8u46766qWhNIZVYlVEH6qhhk1zX_RFa7bJ9V2x4G_AZvR0w7QNJ0Ui_9NM9gvVx8Ty7doRuDm4ee37q0KHmcC64iqnDODyUrfFSAWFJPhn6MQs0Zk-gvcrQaEv0KqXCmC_xCUR2lBf5zOK53tXoJxCv9IkS7SnOmAqFCUWIUxiKaRbKIs5I74FmxpPkAVa47ZmzTEWTZSDLV6WlakmnswPvxkl89Tse_mM-trNPhl21SHHGoC2s9fPybkYxy0jsoWa12XZOa_l3cp5zdz8PQrAkRCBY48KJXn3FEGN8ai-lAdKBYI4MG-z6k1NVPA_odCk7Rd3bgg1XB30O_90XP_ov7FTzCjyD6vKRzOG6vO_UaXa5WTuEo2kR4FAmdwslsfjFf6vPHH58XeJ4vVl-_ITXhydT8jLeN0SyR
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VcoALgpafQAEjAQdQpNhOnOSAUNVSbWm7p1bqLcSxo0baJqWbLNqX4hkZO3FWS9Xeeo0nia0Zj2fGM98AfMTJCSpy5StJmR8qnfsyydHn4aKkZRoEua2FOZmKyVn48zw634C_rhbGpFU6nWgVtWoKEyNHJ51Gpu4xEN-vfvuma5S5XXUtNHqxONLLP-iyzb8d7iN_PzF28ON0b-IPXQX8Igp461NVirRIhI6pxrMrkkxxXEgqaSAjnuLkCsYk2j0CpV_ib6VGjR1ypanxNkKO330AD0POY4PVn-ytUkoMkImtZuLCFyyI3S1qYEFLuQHhpQb1LxZ-un4O3jBub-Zo_ndRa8-_g6fwZDBcyW4vac9gQ9dbsL1bo9N-uSSfiU0ltTH6LfD2K93iswF0dEamDvN_GxYOBoU0JXHtWVpSDd1ZF5oYM3poKmaJiu666C6r2gyQygZBtCJ9EQ6SG4gBIqsmX-TVrEcdX-LniO0-SOadNJGm-XM4uxc2vYDNuqn1KyBByVWEapwWTIeJjpISnT4W0zyWKs1L4UHgWJEVAzK6adAxy0ZMZ8u9zGTDGe5lqQdfxleueliQu4h3HH-zQUPMs5U8e_BhHMa9bS5s8lo33Tyz7cIEp4LdTsNQiyZJmLDQg5e9yIwzQnfaKmgP4jVhGgkMtvj6SF1dWIzxKBEUTXUPvjqxW0391oW-vnuh7-HR5PTkODs-nB69gcc4kPQ5UDuw2V53-i2ad618Z_cUgV_3vYn_AWd4X6o
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIiEuCFoegQJGAg6gqLGdOMkBoYpl1VJYcaDS3kIcOyLSNilNdtH-NX4dYydOtVTtrdd4Yo01D8_Y428AXiNzgopc-UpS5odK575Mcsx5uChpmQZBbt_CfJuJw5Pwyzyab8Ff9xbGlFU6n2gdtWoKc0aOSTqNzLvHQOyXQ1nE98n049lv33SQMjetrp1GryLHev0H07f2w9EEZf2GsennH58O_aHDgF9EAe98qkqRFonQMdW4j0WSKY6LSiUNZMRTZLRgTGIMJNASJLIgNXrvkCtNTeYRcpz3FtyOOW6baEvxfEz2DDC7TfZCLnzBgtjdqAYWwJQbQF5qEABj4aebe-KlQPdyveZ_l7Z2L5zeh3tDEEsOeq17AFu63oHdgxoT-NM1eUtsWak9r98Bb1LpDr8NAKQLMnP4_7uwcpAopCmJa9XSkWro1LrSxITUQ4MxS1Qsz4vlaVWbAVLZAxGtSP8gB8kN3ACRVZOv8mrRI5CvcTpiOxGSdinNqVP7EE5uREyPYLtuav0ESFByFaFLpwXTYaKjpMQEkMU0j6VK81J4EDhRZMWAkm6adSyyEd_ZSi8zlXFGelnqwbvxl7MeIuQ64j0n32zwFm12odsevBqH0c7N5U1e62bZZrZ1mOBUsKtpGHrUJAkTFnrwuFeZkSNMra2z9iDeUKaRwOCMb47U1S-LNx4lgmLY7sF7p3YXrF-50KfXL_Ql3EHzzb4ezY6fwV38nvTlUHuw3Z0v9XOM9Dr5wpoUgZ83bcP_AELgZAw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+different+innovative+formulations+of+curcumin+for+improved+relative+oral+bioavailability+in+human+subjects&rft.jtitle=European+journal+of+nutrition&rft.au=Purpura%2C+Martin&rft.au=Lowery%2C+Ryan+P.&rft.au=Wilson%2C+Jacob+M.&rft.au=Mannan%2C+Haider&rft.date=2018-04-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=1436-6207&rft.eissn=1436-6215&rft.volume=57&rft.issue=3&rft.spage=929&rft.epage=938&rft_id=info:doi/10.1007%2Fs00394-016-1376-9&rft.externalDocID=10_1007_s00394_016_1376_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1436-6207&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1436-6207&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1436-6207&client=summon